Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Medical Sciences

TÜBİTAK

2005

Brucellosis

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Prevalence Of Brucellozis In The Rural Area Of Kayseri, Central Anatolia, Turkey, Fevzi̇ye Çeti̇nkaya, Meli̇s Naçar, Ayşe Nedret Koç, Selma Gökahmetoğlu, Tülay Aydin Jan 2005

Prevalence Of Brucellozis In The Rural Area Of Kayseri, Central Anatolia, Turkey, Fevzi̇ye Çeti̇nkaya, Meli̇s Naçar, Ayşe Nedret Koç, Selma Gökahmetoğlu, Tülay Aydin

Turkish Journal of Medical Sciences

This study was planned in order to make good the lack of information about population-based data on the prevalence of brucellosis in the Kayseri region. This cross-sectional research was performed on 1850 individuals living in the rural regionaround Kayseri. People aged 15-85 in 9 districts in this rural areas were interviewed and blood samples were screened using the Rose Bengal Agglutination test. The overall prevalence of brucellosis was 3.4%. Although the rate was higher in females (3.7%) than in males (2.9%), there was no significant difference. The lowest prevalence (2.0%) was observed in the 25-34 age group, and the highest …


Lymphocyte Subpopulations In Patients With Acute Brucellosis, İlhami̇ Çeli̇k, H. Handan Akbulut Jan 2005

Lymphocyte Subpopulations In Patients With Acute Brucellosis, İlhami̇ Çeli̇k, H. Handan Akbulut

Turkish Journal of Medical Sciences

The aim of this work was to evaluate changes in lymphocyte subpopulations, especially helper and cytotoxic T cells, in acute brucellosis patients undergoing treatment. Forty-three acute brucellosis patients were included in the study. Twenty healthy subjects served as controls. Total lymphocytes and the CD3^+, CD4^+, CD8^+, CD19^+ and CD (16+56)^+ subpopulations were counted by two-color flow cytometric analysis. The CD4+ counts in patients before and after treatment were not statistically different (p = 0.7), but healthy subjects had significantly more of these cells (p = 0.001 and p = 0.001 compared to pre- and post-treatment patients, respectively). The CD8^+ counts …